Selskabets formål er udvikle avancerede medicinske produkter samt al virksomhed, som efter ledelsens skøn har forbindelse hermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -13.2 mio. | -22.4 mio. | 108.8 mio. | 102.2 mio. | 20 | |
CVR: 40666699
Compared to 992 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Ulrik Schulze joined the board
Robert Samuel joined the board
Lindhardt Holdings ApS registered with 5% ownership
MTI Biograil Invest A/S registered with 15% ownership
registered with 10% ownership
registered with 15% ownership
Karsten Lindhardt joined the board
Steffen Wagner joined the board
Anke Cassing left the board
registered with 5% ownership
Companies in the same industry and area
CVR 26110262
CVR 32304362
CVR 37456136
CVR 38179845
CVR 38434969
companydata.dk